KalVista Receives Approval for Its Initial On-Demand Pill Targeting Hereditary Angioedema

KalVista Receives Approval for Its Initial On-Demand Pill Targeting Hereditary Angioedema

KalVista Receives Approval for Its Initial On-Demand Pill Targeting Hereditary Angioedema